CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | LEUNG SANDRA Director | Grant or award | +5,789 | $5.83 | $34K | 102,859 |
| 2026-06-30 | LEUNG SANDRA Director | Grant or award | +6,845 | $4.93 | $34K | 97,070 |
| 2026-05-22 | LEUNG SANDRA Director | Grant or award | +45,871 | 90,225 | ||
| 2026-03-31 | LEUNG SANDRA Director | Grant or award | +5,946 | $5.40 | $32K | 44,354 |
| 2025-12-31 | LEUNG SANDRA Director | Grant or award | +4,586 | 38,408 | ||
| 2025-09-30 | LEUNG SANDRA Director | Grant or award | +3,673 | 33,822 | ||
| 2025-07-25 | LEUNG SANDRA Director | Grant or award | +30,149 | 30,149 |
Page 1 of 1 · 7 trades